CXCL10 and vitiligo: We show that CXCL10-induced apoptosis occurs to a greater extent in melanocytes extracted from vitiligo patients and that this apoptosis can be prevented by using CXCR3 antagonists, by silencing CXCR3B, or by using caspase-inhibitors.